Vytrus Biotech SA
MAD:VYT

Watchlist Manager
Vytrus Biotech SA Logo
Vytrus Biotech SA
MAD:VYT
Watchlist
Price: 5.9 EUR 1.72% Market Closed
Market Cap: 45.1m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one VYT stock under the Base Case scenario is 5.66 EUR. Compared to the current market price of 5.9 EUR, Vytrus Biotech SA is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VYT Relative Value
Base Case
5.66 EUR
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.8
P/S
P/S
Price to Sales
8.8
vs History
0
vs Industry
8
Median 3Y
5
Median 5Y
4.4
Industry
1.1
Forward
6.3
More Details
43.7
P/E
P/E
Price to Earnings
43.7
vs History
0
vs Industry
17
Median 3Y
29.9
Median 5Y
27.1
Industry
18.4
Forward
23.4
More Details
24.2
P/OCF
P/OCF
Price to OCF
24.2
vs History
37
vs Industry
26
Median 3Y
17.6
Median 5Y
13.8
Industry
12.6
More Details
338.4
P/FCFE
P/FCFE
Price to FCFE
338.4
vs History
0
vs Industry
15
Median 3Y
31
Median 5Y
-67.1
Industry
17.2
More Details
6.1
P/B
P/B
Price to Book Value
6.1
vs History
0
vs Industry
17
Median 3Y
4.4
Median 5Y
4.2
Industry
1.6
More Details
8.6
EV/S
EV/S
Enterprise Value to Sales
8.6
vs History
0
vs Industry
9
Median 3Y
4.8
Median 5Y
4.5
Industry
1.2
Forward
6.1
More Details
10.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.5
vs History
0
vs Industry
32
Median 3Y
5.9
Median 5Y
5.4
Industry
4
More Details
23.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.6
vs History
0
vs Industry
23
Median 3Y
12
Median 5Y
11.6
Industry
10.3
Forward
14.5
More Details
42.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
42.9
vs History
23
vs Industry
12
Median 3Y
33.2
Median 5Y
27.9
Industry
13.2
Forward
21.4
More Details
23.6
EV/OCF
EV/OCF
Enterprise Value to OCF
23.6
vs History
37
vs Industry
27
Median 3Y
18.3
Median 5Y
13.2
Industry
13.2
More Details
67.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
67.8
vs History
0
vs Industry
6
Median 3Y
-32
Median 5Y
-63.1
Industry
16.3
More Details
5.1
EV/IC
EV/IC
Enterprise Value to IC
5.1
vs History
0
vs Industry
19
Median 3Y
2.9
Median 5Y
2.9
Industry
1.3
More Details

Multiples Across Competitors

VYT Competitors Multiples
Vytrus Biotech SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Vytrus Biotech SA
MAD:VYT
44.6m EUR 8.8 43.7 23.6 42.9
FR
L'Oreal SA
PAR:OR
212.2B EUR 4.8 34.7 19.7 24
UK
Unilever PLC
LSE:ULVR
114.3B GBP 2.2 23.8 164.4 191.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
6.2T INR 9.8 58.1 40.8 45
UK
HALEON PLC
LSE:HLN
33B GBP 2.9 22.9 13.7 15.5
US
Estee Lauder Companies Inc
NYSE:EL
31.9B USD 2.2 -28.1 18.4 31.6
DE
Beiersdorf AG
XETRA:BEI
21.8B EUR 2.2 24.8 12.3 15.7
JP
Kao Corp
TSE:4452
3.1T JPY 1.9 27.3 12.2 18.9
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9 69.7 42 45.5
IN
Dabur India Ltd
NSE:DABUR
919.1B INR 7.3 52 38.8 48
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
ES
Vytrus Biotech SA
MAD:VYT
Average P/E: 39.6
43.7
48%
0.9
FR
L'Oreal SA
PAR:OR
34.7
8%
4.3
UK
Unilever PLC
LSE:ULVR
23.8
13%
1.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
58.1
8%
7.3
UK
HALEON PLC
LSE:HLN
22.9
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -28.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
24.8
9%
2.8
JP
Kao Corp
TSE:4452
27.3
12%
2.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
69.7
20%
3.5
IN
Dabur India Ltd
NSE:DABUR
52
12%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ES
Vytrus Biotech SA
MAD:VYT
Average EV/EBITDA: 38.6
23.6
39%
0.6
FR
L'Oreal SA
PAR:OR
19.7
6%
3.3
UK
Unilever PLC
LSE:ULVR
164.4
3%
54.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
40.8
9%
4.5
UK
HALEON PLC
LSE:HLN
13.7
5%
2.7
US
Estee Lauder Companies Inc
NYSE:EL
18.4
15%
1.2
DE
Beiersdorf AG
XETRA:BEI
12.3
2%
6.1
JP
Kao Corp
TSE:4452
12.2
7%
1.7
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
42
14%
3
IN
Dabur India Ltd
NSE:DABUR
38.8
11%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ES
Vytrus Biotech SA
MAD:VYT
Average EV/EBIT: 47.9
42.9
57%
0.8
FR
L'Oreal SA
PAR:OR
24
6%
4
UK
Unilever PLC
LSE:ULVR
191.7
3%
63.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
45
9%
5
UK
HALEON PLC
LSE:HLN
15.5
5%
3.1
US
Estee Lauder Companies Inc
NYSE:EL
31.6
24%
1.3
DE
Beiersdorf AG
XETRA:BEI
15.7
2%
7.8
JP
Kao Corp
TSE:4452
18.9
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
45.5
14%
3.3
IN
Dabur India Ltd
NSE:DABUR
48
13%
3.7
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
VYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
VYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VYT stock valuation using valuation multiples.
Wall Street Estimates
VYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 277,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.